首页> 外文期刊>Journal of Medicinal Chemistry >Phthalocyanine Derivatives Possessing 2-(Morpholin-4-yl)ethoxy Groups As Potential Agents for Photodynamic Therapy
【24h】

Phthalocyanine Derivatives Possessing 2-(Morpholin-4-yl)ethoxy Groups As Potential Agents for Photodynamic Therapy

机译:酞菁衍生物具有2-(Morpholin-4-yl)乙氧基作为光动力疗法的潜在药物

获取原文
获取原文并翻译 | 示例
           

摘要

Three 2-(morpholin-4-yl)ethoxy substituted phthalocyanines were synthesized and characterized. Phthalocyanine derivatives revealed moderate to high quantum yields of singlet oxygen production depending on the solvent applied (e.g., in DMF ranging from 0.25 to 0.53). Their photosensitizing potential for photodynamic therapy was investigated in an in vitro model using cancer cell lines. Biological test results were found particularly encouraging for the zinc(II) phthalocyanine derivative possessing two 2-(morpholin-4-yl)ethoxy substituents in nonperipheral positions. Cells irradiated for 20 min at 2 mW/cm(2) revealed the lowest IC50 value at 0.25 mu M for prostate cell line (PC3), whereas 1.47 mu M was observed for human malignant melanoma (A375) cells. The cytotoxic activity in nonirradiated cells of novel phthalocyanine was found to be very low. Moreover, the cellular uptake, localization, cell cycle, apoptosis through an ELISA assay, and immunochemistry method were investigated in LNCaP cells. Our results showed that the tested photosensitizer possesses very interesting biological activity, depending on experimental conditions.
机译:合成并表征了三个2-(吗啉-4-基)乙氧基取代的酞菁。酞菁衍生物显示出中等至高的单重态氧产量量子产率,具体取决于所施加的溶剂(例如,在DMF中为0.25至0.53)。在使用癌细胞系的体外模型中研究了它们对光动力疗法的光敏潜力。对于在非外围位置具有两个2-(吗啉-4-基)乙氧基取代基的锌(II)酞菁衍生物,发现生物学测试结果特别令人鼓舞。以2 mW / cm(2)照射20分钟的细胞显示,前列腺细胞系(PC3)的IC50值最低,为0.25μM,而人类恶性黑色素瘤(A375)细胞则观察到1.47μM。发现新型酞菁在未辐射的细胞中的细胞毒活性非常低。此外,还研究了LNCaP细胞的细胞摄取,定位,细胞周期,通过ELISA测定的凋亡和免疫化学方法。我们的结果表明,根据实验条件,所测试的光敏剂具有非常有趣的生物学活性。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号